Clinical outcomes of external beam radiotherapy in patients with localized prostate cancer: Does dose escalation matter?
Chia Ching LeeKeith Hc LimDavid Wt ChiaYew Lam ChongKeng Siang PngKian Tai ChongYu Yang SoonJeremy Chee Seong TeyPublished in: Asia-Pacific journal of clinical oncology (2019)
Men with localized prostate cancer treated with EBRT in our population had excellent 5-year OS and biochemical outcomes. Dose escalation did not significantly improve these outcomes but was associated with significantly increased risk of grade ≥2 proctitis in our population. Future studies should be performed to identify patients who will benefit the most from dose-escalated EBRT.